It’s already been a big year for Algeon Materials, a biotechnology company creating sustainable, biodegradable alternatives to plastic from kelp. It recently completed its journey with the inaugural cohort of the startBlue Accelerator Program, an eight-month incubator for blue-tech startups.
Findings from a new University of California San Diego Rady School of Management study reveal people often hurt others because in their mind, it is morally right or even obligatory to be violent and as a result, they do not respond rationally to material benefits.
A study from the University of California’s Rady School of Management finds teammates who thanked each other before performing a high-stress task had a better cardiovascular response, compared to teams who did not express gratitude.
UC San Diego is one of the world’s most prominent hubs for scientific and technological innovation focused on the world’s oceans, a status underscored by the startBlue Accelerator Program, a collaborative venture between Rady School of Management and Scripps Institution of Oceanography.
As many State legislatures consider weakening voter protections and Congress debates new voting rights laws, recent research from the University of California San Diego’s Rady School of Management reveals that the 1965 Voting Rights Act contributed to improvements of the economic status of Blacks.
Republican-leaning counties saw a sharp rise in birth rates compared to Democratic-leaning counties after Donald J. Trump’s surprise win in the 2016 presidential election, reveals a forthcoming study from the University of California San Diego.
Charitable giving increased in counties that experienced COVID-19-related deaths, reveals a new study from the University of California San Diego’s Rady School of Management published in Nature’s Scientific Reports.
Financial incentives and other nudges have been used to help increase vaccination rates across the nation, but new research from the University of California San Diego’s Rady School of Management reveals that compensations need to be large—at least $100—to reduce vaccine hesitancy.